Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MCP-1 (MCAF) | 6999.5 | 44 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 129.0 | 47 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 470.0 | 57 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 498.5 | 50 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 715.5 | 48 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 165.5 | 52 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 73.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 3941.5 | 44 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 5292.5 | 50 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 5357.5 | 58 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 7994.5 | 46 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 5320.0 | 51 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | MCP-1 (MCAF) | 6145.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP-1 (MCAF) | 111.0 | 48 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | MCP-1 (MCAF) | 75.0 | 50 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP-1 (MCAF) | 153.5 | 50 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | MCP-1 (MCAF) | 120.0 | 54 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MCP-1 (MCAF) | 77.5 | 54 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | MCP-1 (MCAF) | 23.5 | 50 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MCP-1 (MCAF) | 135.0 | 57 | ||||
RA2159 | 2 | MCP-1 (MCAF) | 120.0 | 53 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MCP-1 (MCAF) | 227.0 | 38 | ||||
N2645 | 2 | MCP-1 (MCAF) | 363.5 | 48 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MCP-1 (MCAF) | 176.5 | 40 | ||||
RA2708 | 2 | MCP-1 (MCAF) | 188.0 | 24 |